Stock Events

Stock Events

Lineage Cell Therapeutics (BT3.F) Q1 2025 Earnings

10MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.04

-0.03

-0.03

-0.02

Details

Expected EPS

-0.027672299999999997

Actual EPS

-0.018448199999999998

Surprise EPS

0.01

Surprise Percent

+33.33%

Description

Lineage Cell Therapeutics (BT3.F) has reported earnings of -0.018448199999999998 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.